Healthcare Triangle, Inc.
HCTI
$2.41
$0.051.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 77.50% | 18.76% | -21.88% | -45.90% | -58.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.50% | 18.76% | -21.88% | -45.90% | -58.90% |
| Cost of Revenue | 77.06% | 36.28% | -9.34% | -40.03% | -57.29% |
| Gross Profit | 79.27% | -34.64% | -59.25% | -65.02% | -64.42% |
| SG&A Expenses | 139.73% | 64.95% | 13.66% | -23.48% | -35.68% |
| Depreciation & Amortization | 311.78% | -20.70% | -175.97% | -117.60% | -70.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.77% | 43.94% | -8.27% | -37.85% | -50.78% |
| Operating Income | -170.57% | -105.87% | -49.32% | -3.51% | 1.07% |
| Income Before Tax | -140.95% | -58.96% | -0.45% | 18.95% | 20.04% |
| Income Tax Expenses | -- | -- | -60.00% | -50.00% | -56.25% |
| Earnings from Continuing Operations | -140.66% | -58.77% | -0.35% | 19.00% | 20.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -140.66% | -58.77% | -0.35% | 19.00% | 20.12% |
| EBIT | -170.57% | -105.87% | -49.32% | -3.51% | 1.07% |
| EBITDA | -188.96% | -159.61% | -382.67% | -294.48% | -254.21% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |